Antilipolytic effect of p-myristyloxy-alpha-methylcinnamic acid (LK-903 acid) as a mechanism of the hypolipidemic action of its alpha-monoglyceride (LK-903).
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D002784:Cholesterol / Q000097:blood; D002934:Cinnamates / Q000008:administration & dosage / Q000494:pharmacology*; D004032:Diet; D004347:Drug Interactions; D005989:Glycerides / Q000008:administration & dosage / Q000494:pharmacology*; D000960:Hypolipidemic Agents; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D051381:Rats; D013997:Time Factors
D002934:Cinnamates; D005989:Glycerides; D000960:Hypolipidemic Agents; D008055:Lipids; C017974:methyl-p-myristyloxycinnamic acid 1-monoglyceride; D002784:Cholesterol